AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$41.01 USD
-1.41 (-3.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $40.94 -0.07 (-0.17%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth F Momentum B VGM
Zacks News
LHC Group (LHCG) & SCP Health to Offer Home Health Services
by Zacks Equity Research
LHC Group (LHCG) collaborates with SCP Health to provide innovative and advanced in-home healthcare services.
Intuitive Surgical (ISRG) Hits 52-Week High: What's Behind It?
by Zacks Equity Research
Investors are optimistic about Intuitive Surgical's (ISRG) strength in its da Vinci surgical system.
West Pharmaceutical (WST) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about West Pharmaceutical's (WST) solid proprietary products segment.
Bowen Center Expands Access to Care via NextGen's (NXGN) Platform
by Zacks Equity Research
NextGen's (NXGN) platform is likely to expand care to the underserved patient pool by improving the access to and delivery of whole-person care.
Walgreens Boots (WBA) Q3 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Walgreens Boots (WBA) revenues improve 12.1% year-over-year in the third quarter on robust growth in the International and United States segments.
3 Reasons to Add AMN Healthcare (AMN) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about AMN Healthcare (AMN) due to its broad array of services and strength in staffing service.
Reasons to Add West Pharmaceutical (WST) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about West Pharmaceutical (WST) due to its solid proprietary products segment.
Buy These 3 Stocks With Momentum Anomaly for Higher Returns
by Zacks Equity Research
Steel Dynamics (STLD), AMN Healthcare (AMN) and Star Bulk Carriers (SBLK) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Are You Looking for a Top Momentum Pick? Why AMN Healthcare Services (AMN) is a Great Choice
by Zacks Equity Research
Does AMN Healthcare Services (AMN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Retain Catalent (CTLT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Catalent (CTLT) owing to its slew of strategic deals, and integrated development and product supply chain solutions.
New Strong Buy Stocks for June 29th
by Zacks Equity Research
GMS, MOD, REVG, AMN, and XPO have been added to the Zacks Rank #1 (Strong Buy) List on June 29, 2021.
Top Ranked Momentum Stocks to Buy for June 29th
by Zacks Equity Research
AMN, INGN, SWBI, and CMRE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 29, 2021
New Strong Buy Stocks for June 25th
by Zacks Equity Research
PATK, AMN, KFY, FCF, and AMD have been added to the Zacks Rank #1 (Strong Buy) List on June 25, 2021.
Top Ranked Momentum Stocks to Buy for June 25th
by Zacks Equity Research
CLF, KFY, AMN, and SBH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 25, 2021
BD's (BDX) PeritX System Gets FDA's Expanded 510(k) Clearance
by Zacks Equity Research
BD's (BDX) receipt of the expanded FDA indication for its PeritX System is expected to lessen the number of hospital trips a patient takes for fluid removal.
Looking for a Growth Stock? 3 Reasons Why AMN Healthcare (AMN) is a Solid Choice
by Zacks Equity Research
AMN Healthcare (AMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why You Should Add Inogen (INGN) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.
PerkinElmer (PKI) to Boost Portfolio via SIRION Acquisition
by Zacks Equity Research
PerkinElmer (PKI) expects to be able to support its cell and gene therapy workflows, and expand its existing research solutions via the latest buyout.
Masimo's (MASI) Wearable Wireless Thermometer Gets FDA Nod
by Zacks Equity Research
Masimo's (MASI) continuous, wearable thermometer is likely to help monitor and track body temperature in all thermometer applications following the FDA's clearance.
Zacks.com featured highlights include: AMN Healthcare Services, American Axle & Manufacturing, Generac, Silicon Motion Technology and Target
by Zacks Equity Research
Zacks.com featured highlights include: AMN Healthcare Services, American Axle & Manufacturing, Generac, Silicon Motion Technology and Target
5 Stocks Trading Near 52-Week High That Can Jump Further
by Aniruddha Ganguly
Investors target stocks that have been on a bullish run lately. Stocks like AMN, AXL, GNRC, SIMO and TGT that are seeing price strength have a high chance of carrying the momentum forward.
New Strong Buy Stocks for June 17th
by Zacks Equity Research
MT, FCF, SNA, DAR, and AMN have been added to the Zacks Rank #1 (Strong Buy) List on June 17, 2021.
AMN Healthcare (AMN) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
AMN Healthcare (AMN) is optimistic about maintaining its strength in staffing service as well as offering a broad array of services.
Masimo's (MASI) ORi-Guided OLV Procedure Favored by New Study
by Zacks Equity Research
Masimo's (MASI) ORi-guided thoracic anesthesia procedure is likely to reduce hospital stay and increase patient safety.
Reasons to Add HealthEquity Stock (HQY) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about HealthEquity (HQY) on its slew of buyouts and strength in HSA.